Premium
O3‐13‐04: Effect of acute anti‐amyloid monoclonal antibody ponezumab (PF‐04360365) dosing on Aβ fractional clearance rate in subjects with mild Alzheimer's disease and in healthy volunteers
Author(s) -
Raunig David,
Burstein Aaron,
Cronenberger Carol,
Andreasen Niels,
Lopez Rene,
Kupiec James,
Bednar Martin
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.1215
Subject(s) - medicine , placebo , dosing , cerebrospinal fluid , gastroenterology , pathology , alternative medicine